{
  "ticker": "SOL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969532",
  "id": "02969532",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250715",
  "time": "1707",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06ltkw5kf7z2l1.pdf",
  "summary": "### **Substantial Holder Disclosure Summary**  \n**Company:** Oncosil Medical Ltd (ASX: OSL)  \n\n#### **Key Changes in Substantial Holding**:  \n- **Substantial Holder:** Washington H. Soul Pattinson and Company Limited (Soul Patts)  \n- **Interest Increase:** Voting power in Oncosil Medical (OSL) via Pengana Capital Group Limited (PCG) rose from **16.52% to 18.19%** (3,422,619 shares).  \n- **Reason for Change:** Purchase of **1,072,917 OSL shares** by PCG subsidiary Pengana Capital Limited on 11 July 2025 (placement trade settlement).  \n\n#### **Material Impact:**  \n- **Soul Patts\u2019 Deemed Interest:** Technical holding due to >20% voting power in PCG, which controls the acquired OSL shares.  \n\n*No other material information identified.*  \n\n*(Note: Omitted boilerplate details, legal references, and non-material entity addresses.)*",
  "usage": {
    "prompt_tokens": 3564,
    "completion_tokens": 214,
    "total_tokens": 3778,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T07:30:34.122330"
}